White Julia R, Halberg Francine E, Rabinovitch Rachel, Green Sheryl, Haffty Bruce G, Solin Lawrence J, Strom Eric A, Taylor Marie E, Edge Stephen B
Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226-4801 , USA.
J Am Coll Radiol. 2008 Jun;5(6):701-13. doi: 10.1016/j.jacr.2008.02.026.
During the past 2 decades, breast conservation therapy (BCT) has become firmly established as a standard therapeutic approach for eligible women with early-stage breast cancer. Breast radiation after conservative surgery is an integral component of BCT, resulting in comparable local control and equivalent survival to mastectomy. Successful breast conservation relies on understanding key elements for patient selection, evaluation, treatment contraindications, radiation therapy methods, and integration with systemic therapy.
The Appropriateness Criteria Committee of the American College of Radiology convened an expert panel to examine BCT for early-stage breast cancer. By using a modified Delphi technique to generate consensus, the expert panel responded to questionnaires on 9 clinical cases that address various key elements of breast conservation. A literature review on BCT led to the generation of an evidence table to support the consensus and overview.
Consensus for appropriateness criteria for BCT was produced for various clinical scenarios commonly encountered in practice. These topics include radiation oncology management issues related to young patient age, sentinel node biopsy, elderly patients, other histology, positive margins, extensive intraductal component, node-positive breast cancer, genetic breast cancer, partial breast irradiation, and systemic therapy. Radiation methods for BCT are reviewed.
The Breast Cancer Panel has generated a consensus of up-to-date guidelines for the appropriate use of radiation for BCT by using a modified Delphi process for the American College of Radiology Appropriateness Criteria.
在过去20年中,保乳治疗(BCT)已牢固确立为符合条件的早期乳腺癌女性的标准治疗方法。保乳手术后的乳房放疗是BCT的一个重要组成部分,其局部控制效果和生存率与乳房切除术相当。成功的保乳治疗依赖于对患者选择、评估、治疗禁忌证、放疗方法以及与全身治疗相结合等关键要素的理解。
美国放射学会适宜性标准委员会召集了一个专家小组,对早期乳腺癌的保乳治疗进行审查。通过使用改良的德尔菲技术达成共识,专家小组对9个临床病例的问卷进行了回复,这些病例涉及保乳治疗的各种关键要素。对保乳治疗的文献综述形成了一个证据表,以支持共识和概述。
针对实践中常见的各种临床情况,制定了保乳治疗适宜性标准的共识。这些主题包括与年轻患者年龄、前哨淋巴结活检、老年患者、其他组织学类型、切缘阳性、广泛导管内成分、淋巴结阳性乳腺癌、遗传性乳腺癌、部分乳房照射和全身治疗相关的放射肿瘤学管理问题。对保乳治疗的放疗方法进行了综述。
乳腺癌专家小组通过为美国放射学会适宜性标准采用改良的德尔菲流程,就保乳治疗中放疗的合理使用达成了最新指南的共识。